Developing a core outcome set for COVID-19 prevention interventions: the COS COVID-P study

No abstract


Kerry Avery, Rhiannon Macefield, Sarah Gorst, Nicola Harman, Susanna Dodd, Mike Clarke, Paula Williamson, Jane Blazeby, on behalf of the COS COVID-P Study Steering Committee


Journal: Cochrane Database of Systematic Reviews
Volume: 12
Issue: 1
Pages: 15 - 18
Year: 2020
DOI: 10.1002/14651858.CD202002

Further Study Information

Current Stage: Completed
Date: July 2020 - August 2020
Funding source(s): This study is supported by National Institute for Health Research (NIHR) Senior Investigator Awards (NF-SI_0513-10025 and NIHR200268), the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol (BRC-1215-20011) and the Royal College of Surgeons of England Bristol Surgical Trials Centre.

Health Area

Disease Category: Infectious disease

Disease Name: Coronavirus

Target Population

Age Range: 0 - 120

Sex: Either

Nature of Intervention: Prevention

Stakeholders Involved

- Clinical experts
- Consumers (patients)
- Guideline developers
- Methodologists
- Patient/ support group representatives
- Regulatory agency representatives
- Researchers
- Statisticians

Study Type

- COS for clinical trials or clinical research


- Literature review
- Semi structured discussion